Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Working Capital Changes (2021 - 2026)

HeartSciences (HSCS) has disclosed Other Working Capital Changes for 5 consecutive years, with -$29503.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 82.16% year-over-year to -$29503.0, compared with a TTM value of $45223.0 through Oct 2025, up 115.57%, and an annual FY2025 reading of -$102293.0, up 56.83% over the prior year.
  • Other Working Capital Changes was -$29503.0 for Q4 2025 at HeartSciences, down from -$28302.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $145141.0 in Q1 2024 and bottomed at -$230240.0 in Q2 2024.
  • Average Other Working Capital Changes over 5 years is -$47518.2, with a median of -$34746.0 recorded in 2024.
  • The sharpest move saw Other Working Capital Changes plummeted 273.43% in 2022, then surged 268.0% in 2023.
  • Year by year, Other Working Capital Changes stood at $75520.0 in 2021, then tumbled by 273.43% to -$130976.0 in 2022, then plummeted by 53.65% to -$201244.0 in 2023, then increased by 17.85% to -$165332.0 in 2024, then soared by 82.16% to -$29503.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for HSCS at -$29503.0 in Q4 2025, -$28302.0 in Q3 2025, and -$26814.0 in Q2 2025.